The Indian agrochemical sector is projected to grow 6-8% in FY27, recovering from a FY24 slowdown. However, this expected volume increase faces significant margin pressures due to global oversupply and intensifying domestic competition. The Indian agrochemical sector is projected to grow 6-8% in FY27, recovering from a FY24 slowdown. However, this expected volume increase faces significant margin pressures due to global oversupply and intensifying domestic competition.
Volume-Led Recovery Expected
CareEdge Ratings forecasts stable growth of 6-8% for India's agrochemicals sector in FY27, a rebound from the sharp correction in FY24. This optimism is driven by steady domestic demand, supported by a rise in cultivated area to about 29.5 million hectares in FY25 and foodgrain production reaching 369 million tonnes. These figures indicate increased agricultural activity, boosting demand for crop protection products. On the export side, India maintains a strong global standing with volumes near 0.7 million tonnes in FY25, and gradual growth is anticipated, backed by stable demand in key markets like the U.S. and Europe.
Navigating Margin Pressures
Despite the positive volume outlook, the sector faces persistent pricing pressures. Global oversupply, particularly from China, continues to suppress international prices, a trend increasingly affecting domestic sales prices. While inventory levels have normalized post-FY24 destocking, competitive pricing remains a significant challenge for profit margins. Stable raw material prices improve cost predictability, but have paradoxically led to fiercer competition, especially in standard product categories. For example, UPL Ltd., with a Market Cap of ₹55,390 Cr and a P/E of 31.53x, faces scrutiny over its Debt/EBITDA ratio of 3.51x. In contrast, PI Industries Ltd. (Market Cap ₹46,076 Cr, P/E 29.4x) is debt-free and shows consistent profit growth, suggesting better positioning against margin declines.
Risks to Recovery
The projected recovery faces considerable risks. Geopolitical tensions, particularly in West Asia, could disrupt energy and logistics costs. Unpredictable monsoon patterns, with forecasts suggesting rainfall at 92% of the long-period average, raise concerns over uneven distribution and crop yields. The regulatory environment is also a concern, with India's pesticide management system long stalled due to decades of delayed legislation and weak enforcement, risking harm to farmers and the environment. Furthermore, intensified domestic competition combined with global oversupply creates a difficult pricing environment. Companies like Rallis India Ltd. (Market Cap ₹5,121 Cr, P/E 27.9x), although debt-free, have shown slower revenue growth (3.41% over five years) and a lower ROE of 6.65% compared to peers, potentially making them more vulnerable to margin compression. Insecticides (India) Ltd., with a lower P/E of 14.19x, suggests market discounting possibly related to its scale or product mix versus larger players.
Analyst Views and Future Outlook
Analysts offer a mixed but cautiously optimistic view. Morgan Stanley maintains an Equal Weight rating on UPL, acknowledging volume outperformance but noting near-term uncertainty. MarketsMOJO has upgraded UPL to 'Hold'. PI Industries has a BUY rating from Motilal Oswal, while Rallis India has a mixed outlook with a BUY from ICICI Direct and a REDUCE from Prabhudas Lilladher. Sector-wide projections range from Crisil's 6-7% growth for FY26 and 8-10% for FY27, to Rubix Data Sciences forecasting a 9% CAGR reaching $14.5 billion by 2027-28. The future trajectory depends on sustained export momentum, a pickup in domestic demand, and the industry's ability to manage ongoing pricing pressures and external volatilities.
